Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
Boehringer Ingelheim
West China Hospital
Incyte Corporation
Insel Gruppe AG, University Hospital Bern
Radboud University Medical Center
Adlai Nortye Biopharma Co., Ltd.
Centre Antoine Lacassagne
Merck Sharp & Dohme LLC
The Netherlands Cancer Institute
Bristol-Myers Squibb
Canadian Cancer Trials Group
Centre Francois Baclesse
Radiation Therapy Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Rigshospitalet, Denmark
Institut de Cancérologie de Lorraine
Soligenix
Radiation Therapy Oncology Group
Johannes Gutenberg University Mainz
University of California, San Francisco
UNICANCER
Vanderbilt-Ingram Cancer Center
AstraZeneca
Radiation Therapy Oncology Group
Ciusss de L'Est de l'Île de Montréal
University of Brasilia
Lund University Hospital
Canadian Cancer Trials Group
British Columbia Cancer Agency
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Swiss Cancer Institute
Rennes University Hospital
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Laval University
Sanofi
Boehringer Ingelheim
Trans Tasman Radiation Oncology Group
University of Louisville
Radiation Therapy Oncology Group
Amgen
Swedish Orphan Biovitrum
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology